A carregar...
The Predictive Efficacy of Tumor Mutation Burden (TMB) on Nonsmall Cell Lung Cancer Treated by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
BACKGROUND: Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer, and the majority of NSCLC patients are diagnosed at the advanced stage. Chemotherapy is still the main treatment at present, and the overall prognosis is poor. In recent years, immunotherapy has developed rapidly....
Na minha lista:
| Publicado no: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7984892/ https://ncbi.nlm.nih.gov/pubmed/33791360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/1780860 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|